STCOSD
ANIP icon

Sageworth Trust Company of South Dakota’s ANI Pharmaceuticals ANIP Stock Holding History

Sageworth Trust Company of South Dakota’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5
Closed – – 265
2022
Q2 		$0 Hold
5
– – ﹤0.01% 580
2022
Q1 		$0 Sell
5
-22
-81% -$820 ﹤0.01% 609
2021
Q4 		$1K Buy
+27
New +$1.16K ﹤0.01% 671

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Sageworth Trust Company of South Dakota's ANIP Position: Q3 2022 in Review

Sageworth Trust Company of South Dakota sold out of ANI Pharmaceuticals (ANIP) in Q3 2022, closing a stake of 5 shares.

Sageworth Trust Company of South Dakota first reported a position in ANIP in Q4 2021 and held it in 3 quarters. The position peaked at $1K in Q4 2021. 126 funds tracked by Wall St. Rank hold ANIP as of Q3 2022.

  • Sageworth Trust Company of South Dakota reported no remaining ANI Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Sageworth Trust Company of South Dakota sold 5 ANI Pharmaceuticals shares in Q3 2022.
  • Sageworth Trust Company of South Dakota first reported a position in ANI Pharmaceuticals in Q4 2021 and held it in 3 quarters.
  • Sageworth Trust Company of South Dakota's ANI Pharmaceuticals position peaked at $1K in Q4 2021.
  • 126 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2022.

Based on Sageworth Trust Company of South Dakota's 13F filing for Q3 2022, filed 2 Nov 2022.